Acid blocking medication usage pre and post liver transplantation
β Scribed by J. Stauffer; H. Bonatti; K. Norman; C. Jean-Pierre; J. Nguyen; J. Gusler; J. Slocum; R. Hinder; S. Achem; K. de Vault; R. C. Dickson; J. Aranda-Michel
- Publisher
- Blackwell Publishing
- Year
- 2007
- Tongue
- German
- Weight
- 207 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0001-544X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Emerging data suggest that the hepatitis B virus (HBV) genotype and the precore and core promoter variants impact the outcome of orthotopic liver transplantation (OLT) for hepatitis B. The aim of this study was to determine if there is a correlation between HBV genotype, precore and core promoter va
Latent or sub-clinical hepatic encephalopathy is a recognized complication of cirrhosis and is thought to represent one end of the spectrum of neuropsychiatric impairment, which occurrs as a result of portal-systemic shunting. We studied the psychometric, analyzed electroencephalography (EEG), and v
Primary biliary cirrhosis (PBC) recurs after orthotopic liver transplantation (OLT) in up to one-third of patients. These patients are typically asymptomatic, can be identified by abnormal liver biochemistries, and have evidence of histologic recurrence on liver biopsy. The effect of treatment on re
Optimal selection of liver transplant candidates and early detection of alcohol relapse after orthotopic liver transplantation (OLT) is necessary to improve long-term outcomes. In this study, urinary ethyl glucuronide (uEtG) was prospectively evaluated as a novel screening tool for alcohol detection